US20120071410A1 - Calcitonin products and therapies for treating inflammatory or degenerative diseases - Google Patents

Calcitonin products and therapies for treating inflammatory or degenerative diseases Download PDF

Info

Publication number
US20120071410A1
US20120071410A1 US13/238,801 US201113238801A US2012071410A1 US 20120071410 A1 US20120071410 A1 US 20120071410A1 US 201113238801 A US201113238801 A US 201113238801A US 2012071410 A1 US2012071410 A1 US 2012071410A1
Authority
US
United States
Prior art keywords
calcitonin
therapeutic agent
inhibitor
subject
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/238,801
Inventor
Nozer M. Mehta
James P. Gilligan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taurus Development Co LLC
Original Assignee
Unigene Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US38507810P priority Critical
Application filed by Unigene Laboratories Inc filed Critical Unigene Laboratories Inc
Priority to US13/238,801 priority patent/US20120071410A1/en
Assigned to UNIGENE LABORATORIES INC. reassignment UNIGENE LABORATORIES INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GILLIGAN, JAMES P., MEHTA, NOZER M.
Publication of US20120071410A1 publication Critical patent/US20120071410A1/en
Assigned to VICTORY PARK MANAGEMENT, LLC, AS COLLATERAL AGENT reassignment VICTORY PARK MANAGEMENT, LLC, AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: UNIGENE LABORATORIES, INC.
Assigned to UGP THERAPEUTICS, INC. reassignment UGP THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: UNIGENE LABORATORIES, INC.
Assigned to TARSA THERAPEUTICS, INC. reassignment TARSA THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: UGP THERAPEUTICS, INC.
Assigned to TAURUS DEVELOPMENT COMPANY LLC reassignment TAURUS DEVELOPMENT COMPANY LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TARSA THERAPEUTICS, INC.
Assigned to UNIGENE LABORATORIES, INC. reassignment UNIGENE LABORATORIES, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: VICTORY PARK MANAGEMENT, LLC
Application status is Abandoned legal-status Critical

Links